Drugs once hailed as a breakthrough in the fight against Alzheimer’s disease do not meaningfully help patients, a major review found Thursday, however some experts criticized the research.
The review by the Cochrane organization – which is considered the gold standard for analyzing existing evidence – looked at drugs that target a plaque called amyloids, which builds up in the brains of Alzheimer’s patients.
Read more HERE
Alzheimer; News from the web:
There is no cure for Alzheimer’s disease, but medication can help manage the condition. Currently, the main drugs used to treat Alzheimer’s are what’s known as symptomatic therapies, meaning they ease symptoms but don’t address the cause of the disease. These include cholinesterase inhibitors and memantine. A more recent entry into the field, lecanemab, may help slow the progression of the disease. Here’s a look at how these medications work.
Read all about it HERE
Alzheimer; News from the web:
Read all about it HERE
Alzheimer; News from the web:
WASHINGTON — Medicare’s “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ever. Officials said Friday a new Alzheimer’s drug is responsible for about half of that.
Read all about it HERE
Alzheimer; News from the web:
The results of the clinical studies submitted by the drug’s manufacturer, Biogen, and the FDA’s accelerated approval, have been highly criticized by experts in the field.
Read all about it HERE
Alzheimer; News from the web:
The recent FDA approval of a new medicine for Alzheimer’s has still some questions about who is eligible to get it, the costs and more. Read the article in our link for today for some insights.
Read all about it HERE